Sarcopenic obesity, or the loss of muscle mass and function associated with excess
adiposity, is a largely untreatable medical condition associated with diminished quality of life …

Phase angle (PhA) is a recently proposed marker of nutritional status in many clinical
conditions. Its use in patients with obesity presents different critical concerns due to the …

Sarcopenia is of important clinical relevance for loss of independence in older adults. The
prevalence of obesity in combination with sarcopenia ('sarcopenic-obesity') is increasing at …

Obesity has been an escalating worldwide health problem for decades, and it is likely a risk
factor of prediabetes and diabetes. Correlated with obesity, the number of diabetic patients …

Background Sarcopenic obesity, defined as the coexistence of low muscle mass and high
adiposity, is associated with cardiovascular disease (CVD) and mortality. However, to what …

Adiponectin regulates metabolism through blood glucose control and fatty acid oxidation,
partly mediated by downstream effects of adiponectin signaling in skeletal muscle. More …

Background & aims Bioimpedance analysis-derived phase angle (PhA), as marker of body
cell mass and cell integrity, might be altered in obesity, a condition which is characterized by …

Background Muscle quality (ie, the expression of muscle function per unit of muscle mass)
has been proposed as a clinically-relevant measure to detect individuals at risk of functional …

Skeletal muscle dysfunction caused by obesity is characterized by the decline in
mitochondrial content and function. 5-Heptadecylresorcinol (AR-C17) is a specific bioactive …

Background Obesity leads to a decline in the exercise capacity of skeletal muscle, thereby
reducing mobility and promoting obesity-associated health risks. Dietary intervention has …